drugset / Trial / NCT01799850

The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle

NCT01799850

RandomizedParallel-groupDouble-blindTreatment

Summary

Subjects with type 2 diabetes will be treated with Actos or placebo for eight weeks and needle biopsies of muscle will quantify changes in any of seven different glucose transport proteins in muscle.

Timeline

Start
2002-03
Primary completion
2004-03
Completion
2004-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pioglitazone Small molecule 30 mg Oral